Integral Health Asset Management, LLC
13F Reported Value
ⓘ$2.5B
incl. option notional
Equity Holdings
ⓘ$2.4B
Option Notional
ⓘ$94.4M
$56.2M puts / $38.2M calls
Holdings
92
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Integral Health Asset Management, LLC disclosed 92 positions worth $2.5B in its Form 13F-HR for Q2 2026 — $2.4B in common stock plus $94.4M of put/call option positions (reported at underlying notional value, not premium at risk), led by $RVMD (Revolution Medicines, Inc.) at 11.5% of the equity portfolio, followed by $INSM and $CYTK. During the quarter the fund opened 30 new positions and exited 28 — including a new stake in $ABT and a full exit from $CYTK. The portfolio is most concentrated in Healthcare (95.7% of disclosed assets). All figures are sourced directly from Integral Health Asset Management, LLC’s Form 13F-HR filing with the SEC under CIK 1773206.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$280.9M1,500,000 sh - 39.4#2,150
Quality
$170.6M1,600,000 sh - 28.1#2,566
Quality
$136.3M1,600,000 sh - 59.4
Quality
$113.8M1,100,000 sh - —
Quality
$81.3M2,000,000 sh - —
Quality
$75.1M1,750,000 sh - 40.8
Quality
$73.4M300,000 sh - 62.4
Quality
$71.3M300,000 sh - —
Quality
$70.8M2,000,000 sh - 33.9
Quality
$61.1M550,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Revolution Medicines, Inc.$RVMD | — | $280.9M | 1,500,000 |
 INSMED Inc$INSM | 39.4#2,150 | $170.6M | 1,600,000 |
 CYTOKINETICS INC$CYTK | 28.1#2,566 | $136.3M | 1,600,000 |
 CVS HEALTH Corp$CVS | 59.4 | $113.8M | 1,100,000 |
 Edgewise Therapeutics, Inc.$EWTX | — | $81.3M | 2,000,000 |
 Vera Therapeutics, Inc.$VERA | — | $75.1M | 1,750,000 |
 Axsome Therapeutics, Inc.$AXSM | 40.8 | $73.4M | 300,000 |
 CARDINAL HEALTH INC$CAH | 62.4 | $71.3M | 300,000 |
 Roivant Sciences Ltd.$ROIV | — | $70.8M | 2,000,000 |
 RHYTHM PHARMACEUTICALS, INC.$RYTM | 33.9 | $61.1M | 550,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Integral Health Asset Management, LLC's 92 positions.
Showing top 10 of 92 holdings.
Sector Allocation
Healthcare
$2.3B
Consumer Staples
$79.8M
Technology
$24.0M
Full Holdings — Integral Health Asset Management, LLC (Q2 2026)
All 92 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $RVMD | Revolution Medicines, Inc. | $280.9M | 11.5% | +0% | — |
| 2 | $INSM | INSMED Inc | $170.6M | 7.0% | +7% | 39.4 |
| 3 | $CYTK | CYTOKINETICS INC | $136.3M | 5.6% | +0% | 28.1 |
| 4 | $CVS | CVS HEALTH Corp | $113.8M | 4.7% | +633% | 59.4 |
| 5 | $EWTX | Edgewise Therapeutics, Inc. | $81.3M | 3.3% | +25% | — |
| 6 | $VERA | Vera Therapeutics, Inc. | $75.1M | 3.1% | +9% | — |
| 7 | $AXSM | Axsome Therapeutics, Inc. | $73.4M | 3.0% | +757% | 40.8 |
| 8 | $CAH | CARDINAL HEALTH INC | $71.3M | 2.9% | +11% | 62.4 |
| 9 | $ROIV | Roivant Sciences Ltd. | $70.8M | 2.9% | +0% | — |
| 10 | $RYTM | RHYTHM PHARMACEUTICALS, INC. | $61.1M | 2.5% | -8% | 33.9 |
| 11 |  $EW | Edwards Lifesciences Corp | $56.5M | 2.3% | +268% | 69.4 |
| 12 | $RVMDPUT | Revolution Medicines, Inc. | $56.2M | — | -60% | — |
| 13 |  $ALHC | Alignment Healthcare, Inc. | $47.6M | 1.9% | -22% | 64.2 |
| 14 |  $MRK | Merck & Co., Inc. | $45.0M | 1.9% | -18% | 59.9 |
| 15 |  $DGX | QUEST DIAGNOSTICS INC | $42.4M | 1.7% | +233% | 69 |
| 16 |  $QURE | uniQure N.V. | $41.5M | 1.7% | +0% | — |
| 17 |  $SRRK | Scholar Rock Holding Corp | $41.3M | 1.7% | +50% | — |
| 18 |  $BSX | BOSTON SCIENTIFIC CORP | $38.4M | 1.6% | +64% | 77.5 |
| 19 |  $BTSG | BrightSpring Health Services, Inc. | $38.4M | 1.6% | -56% | 63.3 |
| 20 |  $ABT | ABBOTT LABORATORIES | $36.3M | 1.5% | NEW | 65.5 |
| 21 |  $UNH | UNITEDHEALTH GROUP INC | $35.3M | 1.4% | NEW | 62.7 |
| 22 |  $LFST | LifeStance Health Group, Inc. | $32.1M | 1.3% | -30% | 63.4 |
| 23 |  $NVS | NOVARTIS AG | $31.3M | 1.3% | -20% | — |
| 24 |  $TNGX | Tango Therapeutics, Inc. | $31.3M | 1.3% | +122% | 17.6 |
| 25 |  $THC | TENET HEALTHCARE CORP | $30.9M | 1.3% | NEW | 66.2 |
| 26 |  $SYRE | Spyre Therapeutics, Inc. | $28.9M | 1.2% | NEW | — |
| 27 |  $NVO | NOVO NORDISK A S | $28.8M | 1.2% | NEW | — |
| 28 |  $DFTX | Definium Therapeutics, Inc. | $25.9M | 1.1% | +38% | — |
| 29 |  $NBIX | NEUROCRINE BIOSCIENCES INC | $25.3M | 1.0% | +0% | 76.5 |
| 30 |  $REGN | REGENERON PHARMACEUTICALS, INC. | $24.9M | 1.0% | -53% | 71 |
| 31 |  $IONSCALL | IONIS PHARMACEUTICALS INC | $23.8M | — | NEW | 23.4 |
| 32 |  $BIIB | BIOGEN INC. | $21.6M | 0.9% | +67% | 64.7 |
| 33 |  $TVTX | Travere Therapeutics, Inc. | $21.3M | 0.9% | NEW | 56.6 |
| 34 |  $LNTH | Lantheus Holdings, Inc. | $21.1M | 0.9% | +52% | 61.1 |
| 35 |  $GKOS | GLAUKOS Corp | $21.0M | 0.9% | -14% | 40.5 |
| 36 |  $ORIC | Oric Pharmaceuticals, Inc. | $20.6M | 0.8% | +36% | — |
| 37 |  $BBIO | BridgeBio Pharma, Inc. | $20.5M | 0.8% | +0% | 36.9 |
| 38 |  $VRTX | VERTEX PHARMACEUTICALS INC / MA | $19.9M | 0.8% | +0% | 75.4 |
| 39 |  $ALMS | ALUMIS INC. | $19.7M | 0.8% | -13% | 7.1 |
| 40 |  $ELV | Elevance Health, Inc. | $19.3M | 0.8% | -33% | 59 |
| 41 |  $CNC | CENTENE CORP | $19.3M | 0.8% | -54% | 58.2 |
| 42 |  $ERAS | Erasca, Inc. | $18.3M | 0.8% | +43% | — |
| 43 |  $LLY | ELI LILLY & Co | $18.0M | 0.7% | +0% | 87.5 |
| 44 |  $ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $16.3M | 0.7% | -33% | 38.7 |
| 45 |  $NVST | Envista Holdings Corp | $15.8M | 0.7% | +71% | 54.9 |
| 46 |  $MDT | Medtronic plc | $15.6M | 0.6% | NEW | 68.7 |
| 47 |  $WAT | WATERS CORP /DE/ | $15.0M | 0.6% | NEW | 60.4 |
| 48 |  $LIVN | LivaNova PLC | $14.8M | 0.6% | +20% | — |
| 49 | $NVOCALL | NOVO NORDISK A S | $14.4M | — | NEW | — |
| 50 |  $FBRX | Forte Biosciences, Inc. | $14.3M | 0.6% | +350% | — |
| 51 |  $MDGL | MADRIGAL PHARMACEUTICALS, INC. | $13.4M | 0.6% | +0% | 40.7 |
| 52 |  $PRAX | Praxis Precision Medicines, Inc. | $13.4M | 0.6% | +0% | — |
| 53 |  $ANRO | Alto Neuroscience, Inc. | $13.2M | 0.5% | +0% | — |
| 54 |  $MLYS | Mineralys Therapeutics, Inc. | $12.1M | 0.5% | -40% | — |
| 55 |  $XENE | Xenon Pharmaceuticals Inc. | $12.1M | 0.5% | +0% | 24 |
| 56 |  $ASND | Ascendis Pharma A/S | $12.0M | 0.5% | -61% | 44.8 |
| 57 |  $ACHC | Acadia Healthcare Company, Inc. | $11.8M | 0.5% | +100% | 36.7 |
| 58 |  $IRTC | iRhythm Holdings, Inc. | $10.7M | 0.4% | NEW | 54.8 |
| 59 |  $BHVN | Biohaven Ltd. | $10.4M | 0.4% | -30% | — |
| 60 |  $BEAM | Beam Therapeutics Inc. | $10.3M | 0.4% | +0% | 34.2 |
| 61 |  $IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $9.9M | 0.4% | NEW | 48.2 |
| 62 |  $GEHC | GE HealthCare Technologies Inc. | $9.6M | 0.4% | NEW | 55.7 |
| 63 |  $RGNX | REGENXBIO Inc. | $9.6M | 0.4% | -47% | 26.4 |
| 64 |  $ABSI | Absci Corp | $9.3M | 0.4% | NEW | 7 |
| 65 |  $BRKR | BRUKER CORP | $9.0M | 0.4% | NEW | 50.8 |
| 66 |  $COR | Cencora, Inc. | $8.5M | 0.3% | NEW | 61.1 |
| 67 |  $COGT | Cogent Biosciences, Inc. | $7.7M | 0.3% | -43% | — |
| 68 |  $ELVN | Enliven Therapeutics, Inc. | $7.6M | 0.3% | NEW | — |
| 69 |  $BIOA | BioAge Labs, Inc. | $7.4M | 0.3% | NEW | 26.8 |
| 70 |  $JAZZ | Jazz Pharmaceuticals plc | $7.2M | 0.3% | NEW | — |
| 71 |  $SANA | Sana Biotechnology, Inc. | $7.0M | 0.3% | -38% | — |
| 72 |  $IVA | Inventiva S.A. | $5.7M | 0.2% | +280% | — |
| 73 |  $TARA | Protara Therapeutics, Inc. | $5.7M | 0.2% | -14% | — |
| 74 |  $ALKS | Alkermes plc. | $5.2M | 0.2% | NEW | — |
| 75 |  $LBRX | LB PHARMACEUTICALS INC | $4.9M | 0.2% | +0% | — |
| 76 |  $KARD | Kardigan, Inc. | $4.8M | 0.2% | NEW | — |
| 77 |  $BNTX | BioNTech SE | $4.7M | 0.2% | NEW | — |
| 78 |  $INSP | Inspire Medical Systems, Inc. | $4.5M | 0.2% | NEW | 63.7 |
| 79 |  $TRVI | Trevi Therapeutics, Inc. | $3.7M | 0.1% | NEW | — |
| 80 |  $IDYA | IDEAYA Biosciences, Inc. | $3.7M | 0.1% | NEW | 36.1 |
| 81 |  $CLDX | Celldex Therapeutics, Inc. | $3.7M | 0.1% | NEW | 8.4 |
| 82 |  $SVRA | Savara Inc | $3.7M | 0.1% | +0% | — |
| 83 |  $RLMD | RELMADA THERAPEUTICS, INC. | $3.5M | 0.1% | +11% | — |
| 84 |  $MOBI | Mobia Medical, Inc. | $3.4M | 0.1% | NEW | — |
| 85 |  $SION | Sionna Therapeutics, Inc. | $3.3M | 0.1% | +50% | — |
| 86 |  $MANE | Veradermics, Inc | $3.1M | 0.1% | NEW | — |
| 87 |  $IKT | Inhibikase Therapeutics, Inc. | $2.7M | 0.1% | +0% | — |
| 88 |  $RZLT | Rezolute, Inc. | $2.6M | 0.1% | -75% | — |
| 89 |  $DNLI | Denali Therapeutics Inc. | $2.6M | 0.1% | NEW | — |
| 90 |  $TENX | TENAX THERAPEUTICS, INC. | $2.4M | 0.1% | +0% | — |
| 91 |  $OLMA | Olema Pharmaceuticals, Inc. | $1.3M | 0.1% | -33% | — |
| 92 |  $AURA | Aura Biosciences, Inc. | $1.2M | 0.1% | NEW | — |
New Positions (30)
$ABT ABBOTT LABORATORIES$36.3M$UNH UNITEDHEALTH GROUP INC$35.3M$THC TENET HEALTHCARE CORP$30.9M$SYRE Spyre Therapeutics, Inc.$28.9M$NVO NOVO NORDISK A S$28.8M$IONSCALL IONIS PHARMACEUTICALS INC$23.8M$TVTX Travere Therapeutics, Inc.$21.3M$MDT Medtronic plc$15.6M$WAT WATERS CORP /DE/$15.0M$NVOCALL NOVO NORDISK A S$14.4M$IRTC iRhythm Holdings, Inc.$10.7M$IART INTEGRA LIFESCIENCES HOLDINGS CORP$9.9M$GEHC GE HealthCare Technologies Inc.$9.6M$ABSI Absci Corp$9.3M$BRKR BRUKER CORP$9.0MExited Positions (28)
$CYTKCALL CYTOKINETICS INC
$AZN ASTRAZENECA PLC$RVMDCALL Revolution Medicines, Inc.
$FMS Fresenius Medical Care AG
$ISRG INTUITIVE SURGICAL INC
$TARS Tarsus Pharmaceuticals, Inc.
$GILD GILEAD SCIENCES, INC.$MLYSCALL Mineralys Therapeutics, Inc.
$ELAN Elanco Animal Health Inc
$DNTH Dianthus Therapeutics, Inc. /DE/
$DXCM DEXCOM INC
$SLNO SOLENO THERAPEUTICS INC
$IRON Disc Medicine, Inc.
$NRIX Nurix Therapeutics, Inc.
$COO COOPER COMPANIES, INC.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Integral Health Asset Management, LLC including:
Track Integral Health Asset Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Integral Health Asset Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Integral Health Asset Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Integral Health Asset Management, LLC (SEC CIK: 1773206), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Integral Health Asset Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.